Tumor-induced Osteomalacia
📧 Sign up to get email alerts when something new happens for Tumor-induced Osteomalacia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Natural History Study of Bone and Mineral Disorders
A ClinicalTrials.gov listing indicates a natural history study of bone and mineral disorders is currently recruiting, focusing on tumor-indu…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Al18F-NOTA-LM3 PET/CT in Patients With TIO [NA]
The clinical trial is recruiting to evaluate Al18F-NOTA-LM3 PET/CT imaging in patients with Tumor-Induced Osteomalacia.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Tumor-induced Osteomalacia Disease Monitoring Program
This document describes an ongoing disease monitoring program for Tumor-induced Osteomalacia. The study is sponsored by Ultragenyx Pharmaceu…
-
CLINICAL_TRIALS research · 2017-04-07Clinical Trial Update: 68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia [EARLY_Phase 1]
Early-phase trial evaluating Ga-68 DOTATATE PET/CT to locate somatostatin receptor–expressing tumors causing oncogenic osteomalacia related …
-
CLINICAL_TRIALS research · 2016-07-06Clinical Trial Update: Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia
An observational clinical trial from National Taiwan University Hospital tracks changes in fibroblast growth factor 23 (FGF23) levels in pat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-01-06Clinical Trial Update: Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Causing Oncogenic Osteomalacia
Clinical trial update examining molecular pathways involved in mesenchymal phosphaturic tumors that cause tumor-induced osteomalacia.